Children's Hospital of Eastern Ontario at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Children's Hospital of Eastern Ontario brings 8 presentations from 5 research groups to ASHG 2026 in Montréal. Its program centres on rare-disease diagnosis, genomic data sharing and therapeutic research. Care4Rare Team brings multi-omic diagnosis across Canada and mosaic variant findings, Care4Rare Canada brings infrastructure for Canadian precision-health research, and Lochmüller Lab brings global prevalence estimates for congenital myasthenic syndromes.

OrganizationASHG 2026 Attendance
2 PIs · 2 Postdocs · 1 PhD Student
Care4Rare Teamcare4rare.ca
~21 people
Generates and shares short-read genome, long-read genome, transcriptome and methylome datasets. Develops Genomics4RD for pan-Canadian rare-disease data sharing and diagnosis.
Funded by Genome Canada, Genome Canada +1 more
›
Genome Canada, Canadian Precision Health Initiative · 2025 to present
“As part of Genome Canada’s Canadian Precision Health Initiative, this four-year pan-Canadian project”
Genome Canada, FORGE · 2011 to 2013
“It was jointly funded by Genome Canada and the Canadian Institutes of Health Research.”
Canadian Institutes of Health Research, FORGE · 2011 to 2013
“It was jointly funded by Genome Canada and the Canadian Institutes of Health Research.”
Source: lab pages
13 platforms and techniques
›
Works with
short-read genome, long-read genome, transcriptome, methylome data, whole-exome sequencing, PacBio HiFi sequencing, Genomics4RD
Techniques
multi-omic approaches, bioinformatics, Next Generation Sequencing, genome-wide sequencing, exome sequencing, rare-disease gene discovery
Source: lab pages
No openings posted
Plenary
Tue Oct 20
5:38 pm
Solving the unsolvable: A systematic multi-omic approach for rare disease diagnosis across Canada
Collaborators: University of Ottawa
Multi-omicsExome/genome sequencingLong-read sequencingLaboratory genetics and genomics
Poster
Fri Oct 23
2:30 pm
Rethinking first-tier genetic testing: From chromosomal microarray to genome-wide sequencing
DiagnosticsMicroarraysExome/genome sequencingEthical, legal, and social implications
Care4Rare Canadacare4rare.ca/our-team
Wet + dry lab~21 people
Generates and shares short-read genome, long-read genome, transcriptome and methylome data for rare-disease research. Builds bioinformatics infrastructure for rapid diagnosis through global data sharing.
Funded by Genome Canada, Genome Canada +1 more
›
Genome Canada, Canadian Precision Health Initiative · 2025 to present
“As part of Genome Canada’s Canadian Precision Health Initiative, this four-year pan-Canadian project”
Genome Canada, FORGE · 2011 to 2013
“It was jointly funded by Genome Canada and the Canadian Institutes of Health Research”
Canadian Institutes of Health Research, FORGE · 2011 to 2013
“It was jointly funded by Genome Canada and the Canadian Institutes of Health Research”
Source: lab pages
10 platforms and techniques
›
Works with
short-read genome, long-read genome, transcriptome, methylome, exome sequencing, Genomics4RD
Techniques
Next Generation Sequencing, genome-wide sequencing, multi-omic approaches, HiFi sequencing
Source: lab pages
No openings posted
Lochmüller Lablochmullerlab.org
Wet + dry lab~38 people
Studies rare neuromuscular disorders using whole-exome sequencing, patient-derived material and mouse/zebrafish models. Work spans diagnosis, biomarkers, pathomechanisms and therapy development.
96 papers since 2024
›
Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses
Nature Medicine, 2025
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Archives of Pediatrics and Adolescent Medicine, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
The Lancet Regional Health - Europe, 2024
Source: OpenAlex author A5062908694
Funded by Canada Research Chairs, CIHR +6 more
›
Canada Research Chairs, Canada Research Chair in Neuromuscular Genomics and Health · active
A federal award that pays part of the chair holder's salary plus research support, five years for Tier 2 and seven for Tier 1.
“Hanns holds the Canada Research Chair in Neuromuscular Genomics and Health and our lab’s work is supported by funding from the Canada Research Chairs program.”
CIHR, CIHR Foundation Grant on Precision Health for Neuromuscular Diseases, FDN-167281 · active
Canada's federal health-research funder, the equivalent of the NIH.
“We are supported by a CIHR Foundation Grant on Precision Health for Neuromuscular Diseases under grant no. FDN-167281”
CIHR, CIHR Network Grant for NMD4C · active
Canada's federal health-research funder, the equivalent of the NIH.
“and by a CIHR Network Grant (jointly funded by Muscular Dystrophy Canada) for NMD4C”
+5 more on the lab page
Source: lab pages
11 platforms and techniques
›
Works with
whole exome sequencing (WES), multispectral optoacoustic tomography (MSOT), AAV vectors
Techniques
deep phenotyping, genomics, transcriptomics, proteomics, immunofluorescence studies, mouse models, zebrafish models, iPSCs
Source: lab pages
Currently hiring
›
“We are always interested in hearing from potential MSc and PhD candidates, postdoctoral fellows and research associates”
Source: lab positions page
Poster
Fri Oct 23
2:30 pm
Estimating the global prevalence of recessive forms of acetylcholine receptor congenital myasthenic syndromes using population allele frequencies
Collaborators: University of Ottawa, uOttawa Brain and Mind Research Institute
Genetic epidemiologyMathematical modelingMendelian disorderMuscular abnormalities
Polavarapu research Grouppolavarapulab.org
Dry lab
Reanalyzes exome, genome and transcriptomic data with the RD-Connect Genome Phenome Analysis Platform. Aims to diagnose rare neuromuscular and neurodevelopmental disorders.
Funded by CIHR
›
CIHR, Postdoctoral Fellowship
Canada's federal health-research funder, the equivalent of the NIH.
“As a postdoctoral fellow at CHEO RI, Dr. Polavarapu held a CIHR Postdoctoral Fellowship”
Source: lab pages
9 platforms and techniques
›
Analyzes
Exome sequencing, Genome sequencing, Transcriptomics, RD-Connect Genome Phenome Analysis Platform
Techniques
Deep clinical phenotyping, Functional validation, Variant interpretation workflows, Proteomic analysis, Genomic reanalysis
Source: lab pages
No openings posted
Poster
Fri Oct 23
2:30 pm
Reanalysis of unsolved consanguineous families with rare complex neurological phenotypes identifies novel phenotype associations and dual molecular diagnoses
Collaborators: University of Ottawa, Ottawa Hospital +1 more
Genotype-phenotype correlationsMendelian disorderNeurodevelopmentalNeurogenetics
Cardiomyopathy Variant Curation Expert Panelclinicalgenome.org/affiliation/50002
Works in clinical genetics.
Poster
Thu Oct 22
4:15 pm
Reclassification of hypertrophic cardiomyopathy variants using adapted ACMG/AMP variant interpretation guidelines
Collaborators: University Health Network
Cardiovascular systemDiagnosticsGenetic testingVariant interpretation
1 more presenter — research group not yet identified

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Children's Hospital of Eastern Ontario

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction